Upload Avatar (500 x 500)
Yaojin Peng
yaojin.peng@ioz.ac.cn
English, Chinese, German
Beijing
Chinese Academy of Sciences
Institute of Zoology
  • Bachelor's in Life Sciences
  • PhD in Law: Maastricht University, Netherlands
  • Published over 20 papers in international journals
  • Researcher at Chinese Academy of Sciences
  • Visiting Researcher at Singapore Management University for 6 months
  • Researcher at Maastricht University
  • 2021: Member of the Youth Innovation Promotion Association of the Chinese Academy of Sciences
  • 2021: Advanced Individual in Stem Cell Social Welfare by the Chinese Society for Cell Biology
Biotechnology Law and Ethics
Intellectual Property and Standards
Science and Technology Policy and Management
  • Knowledge Graphs of Ethical Concerns of Cerebral Organoids, Lulu Ding, Zhenyu Xiao, Xia Gong, Yaojin Peng*, 2022
  • A framework for the responsible reform of the 14-day rule in human embryo research, Yaojin Peng*, Jianwei Lv, Zhenyu Xiao, Lulu Ding, Qi Zhou*, 2022
  • Developing standards to support the clinical translation of stem cells, Jiani Cao, Jie Hao, Lei Wang, Yuanqing Tan, Yuchang Tian, Shiyu Li, Aijin Ma, Boqiang Fu, Jianwu Dai, Peijun Zhai, Peng Xiang, Yong Zhang, Tao Cheng*, Yaojin Peng*, Qi Zhou*, Tongbiao Zhao*, 2021
  • Requirements for human cardiomyocytes, Miao Yu, Wei Lei, Jiani Cao, Lei Wang, Aijin Ma, Zhen-Ao Zhao, Huang-Tian Yang, Zhenya Shen, Feng Lan, Feng Cao, Ping Liang, Xuetao Pei, Andy Peng Xiang, Junying Yu, Yu Zhang, Yong Zhang, Qiyuan Li, Jiaxi Zhou, Jun Wei, Yaojin Peng, Huanxin Zhu, Lingmin Liang, Nan Cao, Boqiang Fu*, Jie Hao*, Tongbiao Zhao*, Shijun Hu*, 2021
  • Ethical and Policy Considerations for Human Embryo and Stem Cell Research in China, Yaojin Peng*, Xiaoru Huang, Qi Zhou*, 2020
  • Stem cell ‘therapy’ advertisements in China: infodemic, regulations and recommendations, Jianwei Lv#, Yeyang Su#, Lingqiao Song, Xia Gong, Yaojin Peng*, 2020
  • Patenting Human Embryonic Stem Cell Related Inventions in China: A Comparative Perspective, Yaojin Peng*, 2018
  • The Patentability of Human Embryonic Stem Cell Technology in China, Yaojin Peng*, 2016
  • The Morality and Ethics Governing CRISPR-Cas9 Patents in China, Yaojin Peng*, 2016
  • Patent Term Extension in the Pharmaceutical Sector: An Asian Comparative Perspective, Yaojin Peng*, 2019
  • UW-Google Intermediary Liability Research Project: Privacy Protection in China, Yaojin Peng
  • Trademark apologetic justice: China’s trademark jurisprudence on reputational harm, Nguyen Xuan-Thao, translated by Yaojin Peng*, 2018
  • The challenges and solutions of the 14-day rule in human embryo research, Yaojin Peng*, Jianwei Lv, 2022
  • China’s Strategies for Governance of Biotechnological Changes and New Ethical Challenges, Yaojin Peng, Qi Zhou*, 2021
  • The Era of Synthetic Biology: Biosafety, Biosecurity and Governance, Yaojin Peng*, 2020
  • Ethical issues and the governance of life science and technology: A case study on human-animal chimeras, Yaojin Peng*, Li Wei, 2020
  • The Era of Biotechnology and Biosafety, Qi Zhou*, Yaojin Peng, 2020
  • Designer baby: How to face it, Yaojin Peng*, 2019
  • Intellectual Property Protection Concerning Stem Cell Research in China: Predicament and Solutions, Yaojin Peng*, 2016
  • Employees’ Invention Compensation Regime in the Netherlands and Its Enlightenment to China, Yaojin Peng*, 2017
  • The Protection of Privacy in China, Yong Wan, Jie Wang, Tianxiang He, Yaojin Peng, Zijiao Cheng, 2017
Biotechnology Law Ethics Intellectual Property Standards Policy Management Stem Cells Gene Editing Synthetic Biology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.